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1. Introduction 
Diabetes mellitus is with 220.000 deaths per year the eighth leading cause of death in high 
income countries (World Health Organization (WHO) 2008). In 2007, over 740.000 people in 
the Netherlands were suffering from diabetes and this number is expected to grow to 1.3 
million people in 2025 (National Institute for Public Health and the Environment (RIVM) 
2010). Worldwide approximately 285 million people had the disease in 2010 and this 
number will increase till 438 million in 2030 (World Diabetes Foundation (WDF) 2010). In 
2000, diabetes was most prevalent in India with 31.7 million cases. China (20.8 million cases) 
and the United States (17.7 million cases) were on the second and third place. Diabetes also 
has a great economic impact on the individual, nation healthcare system and economy 
(International Diabetes Federation (IDF) 2010).  
Type 1 diabetes accounts for 5% of all cases of diabetes worldwide. Of this 5% the vast 
majority are children. In type 1 diabetes the body does not produce insulin (American 
Diabetes Association (ADA) 2010).The disease has a strong genetic component, inherited 
mainly through the HLA complex but the exact cause is unknown. Most likely there is an 
environmental trigger in genetically susceptible people that causes an immune reaction. 
The body's white blood cells mistakenly attack the insulin-producing pancreatic β-cells 
(U.S. National Library of Medicine 2011). Putative environmental triggers include viruses 
(e.g. enteroviruses), environmental toxins (e.g. nitrosamines) or foods (e.g. early exposure 
to cow’s milk proteins, cereals or gluten) (Daneman D 2006). This ‘food’  trigger explains 
why type 1 diabetes is less common in people who were breastfed and in those who first 
ate solid foods at later ages (Sadauskaitė-Kuehne V et al. 2004; American Diabetes 
Association (ADA) 2010). 
People with type 1 diabetes also have an increased risk of developing some serious and life 
threatening complications. This involves acute complications, like hyperglycaemia and 
hypoglycaemia which can lead to a coma, but also chronic complications (National Institute 
for Public Health and the Environment (RIVM) 2007). Chronic complications can be 
subdivided into macrovascular and microvascular complications. Cardiovascular disease is 
the major macrovascular complication and includes mainly myocardial infarction and stroke 
(American Diabetes Association (ADA) 2010). The risk for cardiovascular disease, is 4-8 
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times higher for people with type 1 diabetes (Soedamah-Muthu SS et al. 2006). The major 
microvascular complications are diabetic nephropathy, diabetic neuropathy and diabetic 
retinopathy (American Diabetes Association (ADA) 2010). Of the patients with type 1 
diabetes approximately 29% develop persistent microalbuminuria (urinary albumin 
excretion rate between 30 and 300 mg/24 h) after 20 years. Of these 29%, 34% progressed 
further to persistent macroalbuminuria (urinary albumin excretion rate > 300 mg/24 h). 
Persistent microalbuminuria is a risk factor for the development of diabetic nephropathy. 
Microalbuminuria can be seen as an early marker of diabetic kidney disease (Hovind P 
2004). Also retinopathy is a common microvascular complication. The 25-year cumulative 
incidences of any visual impairment and severe visual impairment are 13% and 3%, 
respectively. Diabetic retinopathy is an important cause of visual impairment (Klein R et al. 
2010). Finally the high incidence of lower extremity amputations also stresses how serious 
the complications of type 1 diabetes are. The overall 25-year incidence of lower extremity 
amputations is 10.1% in 943 American type 1 diabetic patients (Sahakyan K et al. 2011). 
These complications account for the major morbidity and mortality associated with type 1 
diabetes, so it is very important to treat them (Daneman D 2006). 
In type 1 diabetes, special attention is paid to balancing the insulin dose with episodes of 
activity and the quantity and timing of food intake to prevent acute episodes of 
hypoglycaemia and hyperglycaemia (Franz MJ et al. 2003). This is important because these 
acute complications can lead to a coma, but also because a high blood glucose concentration 
(glycosylated hemoglobin (HbA1c) ≥ 7%) in people with diabetes increases the risk for 
macrovascular as well as microvascular complications. Other risk factors for these chronic 
complications are smoking, obesity, physical inactivity, high blood pressure and high 
cholesterol levels. Also people with a longer history of diabetes have a higher risk (National 
Institute for Public Health and the Environment (RIVM) 2007). Furthermore it is important 
to realise that the microvascular complications lie on the pathway between diabetes and 
cardiovascular disease. Nephropathy for example is an important risk factor for 
cardiovascular disease in people with type 1 diabetes (Jensen T et al. 1987). 
Recent studies have shown that people with type 1 diabetes eat a more atherosclerosis-
prone diet. This includes a high intake of energy from saturated fat and a low intake of fiber, 
fruits and vegetables, which could increase the risk of the development of atherosclerosis. 
An atherogenic diet may contribute to the risk of cardiovascular disease (Øverby NC et al. 
2006; Snell-Bergeon JK et al. 2009). It has been demonstrated that  80%-90% of type 2 
diabetes  and coronary heart disease cases can be prevented by healthy lifestyle behavior 
with a focus on healthy diet and exercise.(Stampfer et al. 2000; Hu et al. 2001; Yusuf et al. 
2004) These studies suggest that there could be a potential role for diet in type 1 diabetes to 
reduce the risk of cardiovascular disease.  
There are more studies suggesting that diet (including alcohol) can play an important role in 
treating the complications of diabetes (Franz MJ et al. 2003; Franz et al. 2010). Several studies 
have reviewed nutritional recommendations for people with diabetes (Franz MJ et al. 2003; 
Toeller M July 2010). But most of these recommendations  combine both type 1 as well as 
type 2 diabetes. Furthermore they are general and not always specific for the different type 
of complications. An overview of the relationship between diet (including alcohol) and 
complications in type 1 diabetic patients is lacking. Also the effect of lifestyle (including 
physical activity and dietary patterns) on complications is still not elucidated for type 1 
diabetic patients. Lack of physical activity together with an atherogenic diet could enhance 
development of complications especially in high risk type 1 diabetic patients. 
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In the following paragraphs of this bookchapter the literature on associations between diet 
(including alcohol) and lifestyle and chronic complications in type 1 diabetic patients will be 
summarized. Since ‘diet’ and ‘lifestyle’ are broad terms the focus will be on macronutrients 
(carbohydrates (including fiber), proteins and fats (including cholesterol), alcohol, physical 
activity and dietary patterns. The paragraphs are divided by nephropathy, retinopathy and 
CVD. In the final paragraphs all recommendations on diet and lifestyle in patients with type 
1 diabetes will be put in perspective with the current literature. 
2. Diet, lifestyle and nephropathy 
Eighteen studies reported an association between macronutrients and type 1 diabetic 
nephropathy. Of these, thirteen reported results for the association between protein and 
nephropathy. The other five focussed on other dietary macronutrients such as fat, 
cholesterol or carbohydrate in relation with nephropathy. There were also three studies that 
reported results for protein as well as carbohydrate or fats and nephropathy. Furthermore 
one study reported an association between alcohol consumption and nephropathy in type 1 
diabetic patients and one study reported an association between physical activity and 
nephropathy in type 1 diabetic patients. No studies were found examining the effect of 
glycaemic index/glycaemic load on nephropathy in type 1 diabetic patients. 
2.1 Macronutrients 
2.1.1 Protein 
Of the thirteen studies that reported an association between protein and nephropathy there 
were three cross-sectional studies (Toeller M et al. 1997; Riley MD& Dwyer T 1998; O'Hayon 
BE et al. 2000), one case control study (Möllsten AV et al. 2001), two cohort studies (Jibani 
MM et al. 1991; Barsotti G et al. 1998), six randomized controlled trials (Brouhard BH& 
LaGrone L 1990; Zeller K et al. 1991; Dullaart RP et al. 1993; Raal FJ et al. 1994; Hansen HP et 
al. 1999; Hansen HP et al. 2002) and a pilot study (Percheron C et al. 1995). These will be 
discussed in the following paragraphs by study design. 
The three cross-sectional studies were not consistent in their conclusions on the effect of 
protein on diabetic nephropathy. O’Hayon et al. (O'Hayon BE et al. 2000) failed to show a 
significant relationship between dietary protein intake and markers of early nephropathy, 
other than creatinine clearance. Toeller et al. (Toeller M et al. 1997) found a significant 
relationship between dietary protein intake and urinary albumin excretion rate (AER). A 
higher AER was  particularly found in people consuming more than 20% of their dietary 
food energy as protein. Riley et al. (Riley MD& Dwyer T 1998) even found the opposite, a 
decreased prevalence of microalbuminuria at high relative intakes of protein. 
In the case-control study (Möllsten AV et al. 2001) total protein intake was not associated 
with the presence of microalbuminuria, but a diet including a high amount of fish protein 
seemed to decrease the risk. Furthermore they could not confirm an association between a 
high total animal protein intake and having microalbuminuria. In contrast to this finding , 
Jibani et al. (Jibani MM et al. 1991) found in their cohort study that a predominantly 
vegetarian diet (low in animal protein) may have an important beneficial effect on diabetic 
nephropathy without the need for a heavily restricted total protein intake. But they were not 
able to determine if the reduction in total protein intake rather than the reduction in the 
fraction of animal origin was primarily responsible for the fall in the fractional albumin 
clearance. Another (Barsotti G et al. 1998) cohort study showed that a low protein diet has a 
protective effect on the residual renal function in type 1 diabetic patients. 
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In conclusion, these studies were not consistent in their conclusions on the effect of protein 
restriction on type 1 diabetic nephropathy. Furthermore there is not enough evidence for 
recommendations about the preferred type of dietary protein. 
Of the six randomized controlled trials reporting an association between protein and 
nephropathy (Table 1), four have reported a decline in glomerular filtration rate (GFR) 
during the low protein diet (protein intake of approximately 0.8 g/kg/day) (Brouhard BH& 
LaGrone L 1990; Dullaart RP et al. 1993; Hansen HP et al. 1999; Hansen HP et al. 2002). In 
one of these four this decline was greater in the low protein diet group than in the usual 
protein diet group, but this difference was not significant (Hansen HP et al. 1999). In two 
studies this decline was greater in the usual protein diet group than in the low protein 
group (Brouhard BH& LaGrone L 1990; Hansen HP et al. 2002). Among these 2 studies, one 
(Brouhard BH& LaGrone L 1990) found a decline that was significantly greater in the usual 
protein group. Another study showed a decline in GFR in the low protein diet group, but 
did not directly compare this with the usual protein group (Dullaart RP et al. 1993). Only 
one study(Raal FJ et al. 1994) reported an increase in GFR during the low protein diet, but 
this increase was not significant. Zeller et al. (Zeller K et al. 1991) used iothalamate clearance 
and creatinine clearance to assess renal function. The rates of decline in both iothalamate 
and creatinine clearence were significantly slower in the patients in the study-diet group 
than in those in the control-diet group.  
Five trials reported an effect of protein on albuminuria (Brouhard BH& LaGrone L 1990; 
Dullaart RP et al. 1993; Raal FJ et al. 1994; Hansen HP et al. 1999; Hansen HP et al. 2002). In 
three of these five trials there was a decline in albuminuria in the low protein diet group as 
well as in the usual protein diet group (Dullaart RP et al. 1993; Hansen HP et al. 1999; 
Hansen HP et al. 2002). Two of these three showed a significant greater decline in 
albuminuria in the low protein diet group than in the usual protein diet group (Dullaart RP 
et al. 1993; Hansen HP et al. 1999). The other two trials showed a decline in albuminuria in 
the low protein diet group and an increase in the usual diet protein group (Brouhard BH& 
LaGrone L 1990; Raal FJ et al. 1994). One of these (Brouhard BH& LaGrone L 1990) found a 
significant difference between the diet groups. Furthermore, another (pilot) study 
(Percheron C et al. 1995) also found a decline in albuminuria and in creatinine clearance. 
They conclude that moderately (protein intake of approximately 1.2 g/kg/day) rather than 
severely protein restricted diets (protein intake of approximately 0.8 g/kg/day) should be 
recommended, because of the lack of compliance with severely protein restricted diets. The 
only trial (Hansen HP et al. 2002) that determined the effect of dietary protein restriction on 
survival and progression to end stage renal disease (ESRD) in diabetic nephropathy 
reported a relative risk of 0.23 (95% CI: 0.07-0.72) for ESRD in patients assigned to a low-
protein diet compared with patients assigned to a usual protein diet.  
In conclusion, protein restriction (protein intake of approximately 0.8 g/kg/day, Table 1) 
had a positive significant effect on albuminuria, but no effect on GFR was found. 
2.1.2 Carbohydrate 
Two cross-sectional studies (Watts GF et al. 1988; Riley MD& Dwyer T 1998) examined the 
association between carbohydrates and nephropathy. In one study (Watts GF et al. 1988) 
type 1 diabetic patients with microalbuminuria consumed a significantly smaller percentage 
of total energy as carbohydrate compared with patients with normal albumin excretion. In 
the other study (Riley MD& Dwyer T 1998) no significant association between energy 
adjusted carbohydrate intake and microalbuminuria was found. This could be due to their  
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study design (cross-sectional), due to a substantial measurement error in the food frequency 
questionnaires (FFQs) and due to the low response rate (61.2%) for participation.  
2.1.3 Fat/cholesterol 
Four cross-sectional studies reported an association between fat and/or cholesterol and 
nephropathy (Watts GF et al. 1988; Bouhanick B 1995; Riley MD& Dwyer T 1998; Toeller M 
et al. 1999 1). One study (Riley MD& Dwyer T 1998) found no significant association 
between energy adjusted monounsaturated fat intake or energy adjusted polyunsaturated 
fat intake and microalbuminuria, but reported a positive association between usual dietary 
saturated fat intake and microalbuminuria. Another study (Watts GF et al. 1988) found a 
significant positive association between total fat intake and microalbuminuria. Another 
study (Bouhanick B 1995) examined the relationship between fat intake and glomerular 
hyperfiltration (GFR > 173 ml/min/1.73m2), a marker for diabetic nephropathy, in type 1 
diabetic patients. They found that excess fat intake may contribute to hyperfiltration in type 
1 diabetic patients. Finally the fourth study(Toeller M et al. 1999 1) found a higher intake of 
cholesterol, total fat and saturated fat in Eastern Europe compared to Southern or North-
Western Europe. They also found more frequent acute and chronic complications (including  
nephropathy) in Eastern Europe people. Since it was a cross-sectional study they could not 
conclude if this was due to the high intake of cholesterol, total fat and/or saturated fat. 
These cross-sectional studies show that there seems to be a detrimental effect of total dietary 
fat intake as well as saturated fat intake on type 1 diabetic nephropathy. No association 
between energy adjusted MUFA and energy adjusted PUFA and microalbuminuria  
was found.  
In a case-control study (Möllsten AV et al. 2001), no association between total fat intake 
and microalbuminuria was found. In a prospective study (Cárdenas C et al. 2004) a 
progression of nephropathy with greater saturated fatty acid (SFA) consumption and 
lesser polyunsaturated fatty acid consumption (PUFA) was demonstrated. Specifically 
with higher SFA-to-PUFA and SFA-to-MUFA ratios. Another prospective cohort study 
(Lee CC et al. 2010) found an association between PUFA and microalbuminuria. They 
found that dietary n-3 PUFAs (eicosapentaenoic acid and docosahexaenoic acid) are 
inversely associated with the degree but not with the incidence of albuminuria in type 1 
diabetes (Lee CC et al. 2010). 
In conclusion these prospective studies are consistent with the cross-sectional studies about 
the detrimental effect of saturated fat on type 1 diabetic nephropathy. The effect of total fat 
intake on nephropathy is still not elucidated. The cross-sectional study of Watts et al. (Watts 
GF et al. 1988) and the case control study of Möllsten et al. (Möllsten AV et al. 2001) were in 
contrast with each other. Also the effect of PUFAs on nephropathy is still doubtful, but there 
seems to be an inverse association between n-3 PUFAs and the degree of albuminuria. 
2.1.4 Alcohol 
In the EURODIAB Prospective Complications Study (Beulens et al. 2008) the association 
between alcohol and nephropathy was analysed cross-sectionally. They found that 
moderate alcohol consumers (30-70 g alcohol per week) had a lower risk of diabetic 
nephropathy, with an odds ratio of 0.36 (95% CI: 0.18-0.71). This association was most 
pronounced for the consumption of wine. 
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2.1.5 Physical activity 
There were no prospective studies on physical activity and type 1 diabetic nephropathy. 
One cross-sectional study (Kriska AM et al. 1991) found the lowest occurrence of diabetic 
nephropathy in people being 7+ hours a week physically active (sports and leisure physical 
activity). 
3. Diet, lifestyle and retinopathy 
Only two studies reported results for the association between macronutrients and type 1 
diabetic retinopathy. Furthermore two studies reported an association between alcohol 
consumption and diabetic retinopathy and one study reported an association between 
physical activity and diabetic retinopathy. No studies were found examining the effect of 
glycaemic index/glycaemic load on retinopathy in type 1 diabetic patients. 
3.1 Macronutrients 
In post-hoc analyses (Cundiff DK& Nigg CR 2005) a positive association between total 
dietary fat,  saturated fat and MUFA with retinopathy progression and retinopathy risk 
factors (mean arterial pressure, LDL/HDL cholesterol ratio, serum triglycerides, HbA1c, 
body mass index, and insulin utilization) was found. Furthermore, a negative association 
between carbohydrates and dietary fiber with retinopathy progression and risk factors was 
found. In addition to this, another cross-sectional study(Toeller M et al. 1999 1) reported a 
higher intake of cholesterol, total fat and saturated fat in Eastern Europe compared to 
Southern or North-Western Europe. They also found more frequent acute and chronic 
complications (including  retinopathy) in Eastern European people. As with nephropathy, 
they could not conclude if this was due to the high intake of cholesterol, total fat and/or 
saturated fat. 
In conclusion there is limited research on the effect of diet on diabetic retinopathy. The 
results of the post hoc analyses should be interpreted carefully, since it is a retrospective 
analysis which can generate hypotheses but not prove them.  
3.1.2 Alcohol 
In cross-sectional analyses of the EURODIAB Prospective Complications Study (Beulens et 
al. 2008) moderate alcohol consumers (30-70 g alcohol per week) had a lower risk of diabetic 
proliferative retinopathy, with an odds ratio of  0.60 (95% CI: 0.37-0.99). This association 
was most pronounced for the consumption of wine. Another cross-sectional study (Moss 
SE et al. 1992) examined whether alcohol consumption was associated with type 1 diabetic 
retinopathy. They found that moderate alcohol consumption was inversely associated 
with the prevalence of retinopathy (OR=0.49, 95% CI: 0.27-0.92) in patients with type 1 
diabetes. 
3.1.3 Physical activity 
One cross-sectional study (Kriska AM et al. 1991) examined the relationship between 
physical activity and the occurrence of retinopathy in type 1 diabetic patients. They found 
no association between physical activity (sports and leisure physical activity) and 
occurrence of retinopathy. 
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4. Diet, lifestyle and cardiovascular disease 
Eight studies reported an association between macronutrients and CVD in type 1 diabetic 
patients. Of these eight, six are cross-sectional studies (Toeller M et al. 1999 1,2,3; Helgeson 
2006; Øverby NC et al. 2006; Snell-Bergeon JK et al. 2009). Only Strychar et al. (Strychar I et 
al. 2009) and Georgopoulos et al. (Georgopoulos A et al. 2000) performed a randomized 
controlled trial. One study reported an association between lifestyle risk factors (including 
alcohol) and atherosclerosis, which is often the underlying cause of CVD (Bishop et al. 2009). 
Eight studies reported an association between physical activity and CVD risk factors (Kriska 
AM et al. 1991; Lehmann R et al. 1997; Fuchsjäger-Mayrl G et al. 2002; Herbst A et al. 2007; 
Valerio G et al. 2007; Bishop et al. 2009; Trigona B et al. 2010; Seeger JPH et al. 2011), and two 
studies reported an association with dietary patterns (Gunther ALB et al. 2008; Liese AD et 
al. 2011). Furthermore no studies were found examining the effect of glycaemic 
index/glycaemic load on CVD in type 1 diabetic patients. 
4.1 Macronutrients 
Data on the relationship between macronutrients and incident CVD is lacking in patients 
with type 1 diabetes. Limited information on macronutrients is available from cross-
sectional studies. Main focus was on fat, in particularly saturated fat, and fiber and CVD 
risk factors were used as a proxy for CVD events. 
4.2 Cross-sectional studies on fat and fiber in relation to CVD 
In more detail, one cross-sectional study (Øverby NC et al. 2006) found a higher than 
recommended percentage of energy intake from fat and saturated fat among type 1 diabetic 
patients compared with healthy same-age control subjects and a lower than recommended 
intake of fiber. They conclude that this higher intake of energy from saturated fat and this 
lower intake of energy from dietary fiber, vegetables and fruits could increase the risk of 
atherosclerosis, which is often the underlying cause of CVD. Another study (Helgeson 2006) 
reported a higher than recommended percentage of energy intake from fat and saturated fat 
among type 1 diabetic patients, but they did not study associations with CVD or CVD risk 
factors. Another cross-sectional study (Toeller M et al. 1999 2) found similar associations 
between dietary fiber and CVD. Higher fiber intake had a protective significant effect 
against CVD in type 1 diabetic women but not in men. In type 1 diabetic men it leads to 
positive changes of the serum cholesterol pattern (higher HDL, lower LDL, lower ratio total 
cholesterol:HDL cholesterol). In another study (Toeller M et al. 1999 3) a significant increase 
in energy adjusted total and LDL-cholesterol levels was associated with higher intakes of 
total fat, saturated fat and cholesterol. This was associated with a higher prevalence of CVD, 
although after adjusting for dietary fiber intake, these associations were attenuated. A third 
study by Toeller et al. (Toeller M et al. 1999 1) found a higher intake of cholesterol, total fat 
and saturated fat in Eastern Europe compared to Southern or North-Western Europe. They 
also found more frequent acute and chronic complications (including  CVD) in Eastern 
European people. However, since it was a cross-sectional study they could not conclude if 
this was due to the high intake of cholesterol, total fat and/or saturated fat.  In the CACTI 
study (Snell-Bergeon JK et al. 2009) found an increased risk of CVD in type 1 diabetic 
patients eating high amounts of fat and saturated fat. Carbohydrates were negatively 
correlated with CHD risk factors (higher total cholesterol, LDL cholesterol, obesity, poorer 
glycaemic control). Furthermore higher intakes of fat and protein were associated with 
greater odds of coronary artery calcium (CAC), which is a strong predictor for coronary 
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events approximating CVD risk. The opposite was true for carbohydrate intake, higher 
intake was associated with a reduced odds of CAC. 
In conclusion a higher intake of total fat as well as saturated fat is positively correlated with 
CVD or CVD risk factors (atherosclerosis and CAC in these studies) and a higher intake of 
carbohydrate is negatively correlated with CVD or CVD risk factors. Furthermore dietary 
fiber is independently related to a lower risk for CVD in type 1 diabetic women. Since all 
these studies were cross-sectional, they could only look at the intake of certain nutrients and 
the prevalence of CVD or CVD risk factors at a certain time point. They could not conclude 
if these are related to each other and if the nutrients are responsible for the lower or higher 
prevalence of CVD.  
4.3 Randomized controlled trials 
Two randomized controlled trials reported an association between macronutrients and CVD 
(Table 2), but demonstrated conflicting conclusions. In one trial (Strychar I et al. 2009), the 
authors concluded that a diet lower in carbohydrate and higher in MUFA might be 
preferable to a diet higher in carbohydrate and lower in MUFA for type 1 diabetic patients. 
This was solely based on the positive effect on triglyceride (TG) levels and plasminogen 
activator inhibitor 1 levels (PAI-1) in the first diet. A significant decrease in PAI-1 was found 
after 6 months in the lower carbohydrate and higher MUFA diet. In the other diet there was 
a significant increase after 6 months of follow up. PAI-1 is an inhibitor of fibrinolysis, a 
process that degrades blood clots. A lower level of PAI-1 means less inhibition and more 
degradation of blood clots, which means a lower chance of developing atherosclerosis. Also 
a decrease in TG levels was found after 6 months following the low carbohydrate/high 
MUFA diet, although this decrease was not significant. In the other diet group there was an 
increase in TG levels, also this increase was not significant. Furthermore they conclude that 
the lower carbohydrate/higher MUFA diet was only a proper choice for nonobese 
individuals with weight control since this diet had induced a weight gain of 2% (1.6 kg) after 
6 months. The other trial (Georgopoulos A et al. 2000) found exactly the opposite using a 
crossover design. They found that a diet high in carbohydrates might be preferable to a diet 
high in MUFA. Mainly because of the higher atherosclerotic risk due to more and bigger 
very low-density lipoprotein (VLDL) particles in the last diet. Furthermore the TG levels did 
not significantly differ between the two diets in this study. 
In conclusion, these trials show that the effect of carbohydrate or MUFA on cardiovascular 
disease risk factors in type 1 diabetic patients is still not elucidated. Although they 
recommend exactly the opposite (higher intake of MUFA preferable vs. higher intake of 
carbohydrate preferable) they both found that a high MUFA or a high carbohydrate diet did 
not affect the TG levels. Their conclusions are based on PAI-1 and VLDL levels, which are 
not such a good predictors for atherosclerosis (and by extension CVD) as TG levels are. 
Furthermore none of these randomized controlled trials examined the potential positive 
effect of dietary fiber on CVD or the potential negative effect of saturated fat found in cross-
sectional studies.  
4.4 Alcohol 
One cross-sectional study (Bishop et al. 2009) reported findings on the association between 
alcohol and cardiovascular disease. No significant association was found between alcohol 
consumption (±13.8 drinks/month) and CAC, a marker of coronary artery atherosclerosis 
(adjusted OR=0.9, 95% CI: 0.8-1.1, p=0.15). The positive effect of moderate alcohol  
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consumption on CVD as in the general population  is not confirmed for type 1 diabetic 
patients in this study. However, this could also be due to the kind of study (cross-sectional) 
and the fact that markers for CVD were used instead of CVD as endpoint. There are no 
prospective studies which have addressed the relation between alcohol and CVD in type 1 
diabetic patients. 
4.5 Physical activity 
Of the eight studies that reported an association between physical activity and CVD there 
were five cross-sectional studies (Kriska AM et al. 1991; Herbst A et al. 2007; Valerio G et al. 
2007; Bishop et al. 2009; Trigona B et al. 2010) and three trials (Lehmann R et al. 1997; 
Fuchsjäger-Mayrl G et al. 2002; Seeger JPH et al. 2011). No prospective cohort studies were 
found. The studies will be discussed in the following paragraphs by study design. 
One study (Kriska AM et al. 1991) examined the relationship between physical activity and 
the occurrence of CVD in type 1 diabetic patients. They found the lowest occurrence of CVD 
in people being 4-7 hours a week  physical active (sports and leisure physical activity). The 
other four cross-sectional studies examined an association between physical activity and 
CVD risk factors. They all found a positive association. Another two studies (Herbst A et al. 
2007; Valerio G et al. 2007) found that increased frequency of regular physical activity was 
associated with lower TG levels. One of these (Herbst A et al. 2007) found besides the 
positive association with TG levels also a positive significant association between regular 
physical activity and HDL cholesterol levels. Another study (Trigona B et al. 2010) found 
that 60 min/day of moderate-to-vigorous physical activity was associated with an enhanced 
endothelial function in type 1 diabetic patients. Impaired endothelial function is considered 
as an early sign of atherosclerosis, which is often the underlying cause of CVD. And finally, 
(Bishop et al. 2009) a significant inverse association between physical activity and CAC, a 
marker of coronary artery atherosclerosis, was demonstrated.  
In conclusion all these studies found a beneficial effect of physical activity on cardiovascular 
risk factors. However, since all these studies were cross-sectional, they could only look at 
physical activity and the prevalence of CVD or CVD risk factors at a certain time point. They 
could not conclude if these are related to each other and if physical activity was responsible 
for the lower prevalence of CVD. 
The three trials reporting an association between physical activity and cardiovascular 
disease risk factors (Table 3) were consistent in their conclusions. They all emphasize an 
important role for physical activity in type 1 diabetic patients. Two studies (Fuchsjäger-
Mayrl G et al. 2002; Seeger JPH et al. 2011) examined the association between physical 
activity and brachial artery flow-mediated dilation (FMD). Endothelial dysfunction is 
reflected by an impaired FMD response and is an early sign of atherosclerosis. An increase 
in FMD was found in type 1 diabetic patients following an exercise training program 
(endurance sports; on average 2 times a week 60 minutes, Table 3). In both trials this 
increase was significant (p=0.038 and p=0.040 respectively). Two studies (Lehmann R et al. 
1997; Fuchsjäger-Mayrl G et al. 2002) examined the impact of physical activity on lipid 
related cardiovascular risk factors (LDL cholesterol, HDL cholesterol and TG). They both 
found a decrease in LDL cholesterol levels in the training group, but only in one of these 
(Lehmann R et al. 1997) this decrease was significant (p=0.02). An additional effect was 
reported in one of these studies (Lehmann R et al. 1997) with a significant increase in HDL 
cholesterol levels (p=0.03) in the training group.  No effect of physical activity on TG levels  
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was found in both studies. Furthermore all three studies (Lehmann R et al. 1997; Fuchsjäger-
Mayrl G et al. 2002; Seeger JPH et al. 2011) assessed physical fitness by VO2max (peak oxygen 
uptake). They all found a positive significant association between physical activity and 
VO2max. The relation between physical fitness and CVD was not examined. 
In conclusion the three trials show that physical activity improves physical fitness as well as 
endothelial function in type 1 diabetic patients. A positive effect on lipid related 
cardiovascular risk factors was only found in one study (Lehmann R et al. 1997). 
4.6 Dietary patterns 
Two cross-sectional studies reported an association between dietary patterns, in this case the 
‘Dietary Approaches to Stop Hypertension’ (DASH) diet, and CVD risk factors (Gunther 
ALB et al. 2008; Liese AD et al. 2011). No cross-sectional or prospective studies were found 
examining the effect of a Mediterranean diet or a Western diet on CVD in type 1 diabetic 
patients.  
One study (Gunther ALB et al. 2008) reported an association between adherence to the 
DASH diet and hypertension in type 1 diabetic patients. They found that a higher adherence 
to this diet amongst type 1 diabetic patients was inversely related to hypertension (OR=0.6, 
95% CI: 0.4-0.9, p=0.007). They did not investigate a possible association between the DASH 
diet and CVD, but used hypertension as the main risk factor for CVD. Another study (Liese 
AD et al. 2011) reported a possible association between the DASH diet and other CVD risk 
factors (total cholesterol, LDL cholesterol, HDL cholesterol, TG, LDL particle density, 
apolipoprotein B, body mass index (BMI), waist circumference, and adipocytokines) than 
blood pressure. A significant and inverse association between the DASH diet and 
LDL/HDL ratio was found. An estimated 0.07 lower LDL/HDL ratio was found in the 
highest adherence group compared with the lowest adherence group. No significant 
association was found between LDL particle density, BMI, waist circumference, 
adipocytokines, or TG and the DASH diet. 
In conclusion a positive effect of adherence to the DASH diet on hypertension and 
LDL/HDL ratio, which are important risk factors for CVD, was found. Unfortunately there 
were no studies found examining the effect of dietary patterns on CVD events. 
5. Current recommendations on diet and lifestyle in patients with type 1 
diabetes put in perspective  
Overall, fiber and saturated fat intake play an important role in type 1 diabetic patients, with 
a beneficial and detrimental effect on the chronic complications respectively. Many 
researchers have shown the inappropriate intake of these nutrients in patients with type 1 
diabetes. A protein restriction diet helped reduce micro/macro albuminuria in known type 
1 diabetic patients with nephropathy, however, the compliance was low. Also moderate 
alcohol intake and physical activity may have beneficial effects in type 1 diabetic patients. 
Most of the findings are consistent with the guidelines for type 1 diabetic patients (Table 4).  
The main limitations are the lack of prospective studies on diet and lifestyle in type 1 
diabetics, lack of randomized controlled trials and the limited number of studies on dietary 
cholesterol, protein, carbohydrates, fat, fiber and no cardiovascular morbidity data. The 
available studies, with their limitations, all indicate that diet and lifestyle play an important 
role in preventing chronic complications of type 1 diabetes. To put the findings in the 
literature in perspective, current nutritional recommendations are evaluated in the  
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following paragraphs at a macronutrient level. Table 4 summarizes the nutritional 
recommendations as well as the lifestyle recommendations for type 1 and type 2 diabetic 
patients. These recommendations are for all diabetic patients in general, based in the 
majority of cases on evidence from type 2 diabetic patients.  
5.1 Carbohydrates 
The  ‘Diabetes and Nutrition Study Group of the European Association for the Study of 
Diabetes’ (DNSG EASD) guidelines for persons with type 1 and type 2 diabetes (Table 4) 
recommend  that the most appropriate intake of carbohydrates consists of vegetables, 
legumes, fruits, wholegrain foods and naturally occurring foods rich in fiber. The fiber 
intake should be ideally ≈ 20 g/1000 kcal/day. Cross-sectional data of the EURODIAB 
Complications Study showed an inverse association between fiber and LDL cholesterol and 
a positive association between fiber and HDL cholesterol. In addition dietary fiber was 
inversely and significantly related to CVD (Toeller M et al. 1999 2). This effect was already 
found with a fiber intake of approximately 8.1 g/1000 kcal, which is below the 
recommended intake. The average fiber intake in type 1 diabetic patients is 8.1 g/1000 kcal, 
but the recommended intake is 20 g/1000 kcal. Recommendation was only achieved in 0.4% 
of the type 1 diabetic population (Toeller M et al. 1996). Data from the EURODIAB 
Prospective Complication Study on fiber intake measured at baseline by 3-day food diaries 
and presented by each center is given in Figure 1. As seen in this figure, even the 10 g/1000 
kcal recommended fiber intake by the ‘American Diabetes Association’ (ADA) was hardly 
achieved  by type 1 diabetic patients. Only Finnish type 1 diabetic patients achieved the 
ADA fiber recommendation of 10 g/1000 kcal Figure 1). Keeping in mind that these samples 
are clinic based and not population based and that these figures may not exactly reflect the 
current nutritional intake, however it gives an indication of the status on fiber intake. 
Although positive effects were already found on CVD with a fiber intake of 8.1 g/1000 kcal, 
we assume that effects could be probably even higher when recommended levels of fiber 
intake are reached. Unfortunately, this positive effect of fiber on CVD and CVD risk factors 
was only found in cross-sectional studies. This makes it very difficult to distinguish cause 
and effect. Further research in prospective studies or randomized controlled trials is needed 
to ascertain the role of fiber in CVD.  
DNSG EASD do not recommend a low carbohydrate diet for type 1 and type 2 diabetic 
patients (Table 4). A low carbohydrate diet does not produce beneficial health effect. It is 
more acceptable to avoid too much foods high in fast available carbohydrates, foods high in 
fat and cholesterol. An earlier quote (Helgeson 2006) expressed this precisely: ‘families of 
adolescents with diabetes may be more concerned that the sugar in candy is going to 
translate into high blood glucose levels today than that the fat in potato chips will translate 
into cardiovascular disease in 10 years’.  
5.2 Fat 
The DNSG EASD guidelines for dietary fat  for persons with type 1 and type 2 diabetes 
recommend a saturated and trans-unsaturated fatty acid consumption of <10% of the total 
energy intake (<8% if LDL cholesterol is elevated). Total fat intake should not exceed 35% of 
total energy and dietary cholesterol should be <300 mg/day (Table 4). Saturated fat is an 
important risk factor for diabetic nephropathy, diabetic retinopathy as well as CVD (Riley 
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MD& Dwyer T 1998; Toeller M et al. 1999 3; Cárdenas C et al. 2004; Cundiff DK& Nigg CR 
2005). The recommended intake is <10% of the total energy intake which was only achieved 
by a  small minority (14%) (Toeller M et al. 1996). Data from the EURODIAB Prospective 
Complication Study on saturated fatty acid intake measured at baseline by 3-day food 
diaries and presented by each center is given in Figure 2. The even lower saturated fatty 
acid recommendation of <7% total energy of the ADA was not achieved by any of the 
centers (Figure 2). All centers indicated in Figure 2 exceed the recommendation of <7% 
saturated fat of the total energy intake. Type 1 diabetic patients from Italy had the lowest 
intake of saturated fatty acids, but this intake was still too high (Figure 2). Again, keeping in 
mind that these samples are clinic based and not population based and that these figures 
may not exactly reflect the current nutritional intake. 
 
 
Fig. 1. Mean fiber intake in 1102 individuals with type 1 diabetes across Europa (Toeller M, 
Soedamah-Muthu 2011) 
Furthermore the DNSG EASD guidelines recommend oils rich in MUFA (10-20% total 
energy) and that PUFA should not exceed 10% of total energy intake (Table 4). There were 
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only a few studies examining the effect of MUFA or PUFA on chronic complications in type 
1 diabetic patients. A positive association was found between MUFA and retinopathy 
(Cundiff DK& Nigg CR 2005) but no association was found between MUFA and PUFA 
and microalbuminuria (Riley MD& Dwyer T 1998). These conclusions are based on post-
hoc analyses and a cross-sectional study respectively and should therefore be interpreted 
carefully. Also the conclusion of Strychar et al. (Strychar I et al. 2009) to recommend a diet 
higher in MUFA and lower in carbohydrate for nonobese type 1 diabetic individuals to 
reduce CVD risk factors is doubtful. Their conclusion is based on PAI-1 and VLDL levels, 
which are not such a good predictors for atherosclerosis (and by extension CVD) as TG 
levels are. And a high MUFA diet did not alter TG levels. Furthermore, the small study 
population of 30 subjects limits the power of their conclusions. In order to make accurate 
recommendations concerning MUFA and PUFA intake for type 1 diabetic patients more 
research with more participants (preferably in a prospective study) is needed.  
 
 
Fig. 2. Mean saturated fatty acid intake in  1102 individuals with type 1 diabetes across 
Europe (Toeller M, Soedamah-Muthu 2011) 
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The recommendation of the DNSG EASD to consume 2-3 servings of oily fish/week and 
plant sources of n-3 fatty acids (Table 4) is consistent with the findings in studies specific for 
type 1 diabetes. The prospective cohort study of Lee et al. (Lee CC et al. 2010) found that 
dietary n-3 PUFAs (eicosapentaenoic acid and docosahexaenoic acid) are inversely 
associated with the degree but not with the incidence of albuminuria in type 1 diabetes. A 
hypothesis is that n-3 PUFAs  decrease urinary AER via anti-inflammatory mechanisms. It 
decreases lipopolysaccharide-induced nuclear factor-kB (NF-kB ) activation and monocyte 
chemoattractant protein (MCP)-1 expression in human renal tubular cells (Lee CC et al. 
2010). Further prospective studies and randomized controlled trials are needed to confirm 
this hypothesis. 
5.3 Protein 
With regards to protein, the DNSG EASD guidelines recommend an intake of 0.8 g/kg 
normal body weight in patients with type 1 diabetes and established nephropathy. There are 
no firm recommendations regarding protein intake for type 1 diabetic patients with 
incipient nephropathy. An intake of 10-20% of total energy is recommended for patients 
with no evidence of nephropathy (Table 4). The recommendation for protein intake is most 
important for patients with diabetic nephropathy. The guideline of a restricted protein diet 
which contains 0.8 g/kg normal body weight for type 1 diabetic patients with established 
nephropathy was demonstrated by previous research. Several randomized controlled trials 
showed that protein normalization (protein intake of approximately 0.8 g/kg/day, Table 1) 
had a positive significant effect on albuminuria, although no effect on GFR was found 
(Brouhard BH& LaGrone L 1990; Zeller K et al. 1991; Dullaart RP et al. 1993; Raal FJ et al. 
1994; Hansen HP et al. 1999; Hansen HP et al. 2002). Even a relative risk of 0.23 (95% CI: 
0.07-0.72) was found for ESRD in patients assigned to a low protein diet compared with 
patients assigned to a usual protein diet (Hansen HP et al. 2002). A hypothesis is that 
excessive protein intake causes renal vasodilatation and glomerular excessive perfusion 
leading to a raised glomerular transcapillary hydraulic pressure gradient ending in 
proteinuria and glomerular damage, conversely, will prevent kidney damage (Percheron C 
et al. 1995). So, indeed protein restriction is beneficial for type 1 diabetic patients with 
established nephropathy. However, we have to mention that although this beneficial effect 
of a restricted protein intake was found in randomized controlled trials, the sample size of 
these trials were really small (maximum of 82 people). Furthermore, we have to consider the 
feasibility of a protein intake of 0.8 g/kg/day. Percheron et al. (Percheron C et al. 1995) 
showed that even with this intake the compliance is poor. Further studies with a larger 
sample size are needed to find a cutoff point for protein intake which would still have a 
positive effect on diabetic nephropathy and its feasibility.  
Alcohol 
The DNSG EASD guidelines for alcohol for persons with type 1 and type 2 diabetes 
recommend a moderate use up to 10 g/day for women and up to 20 g/day for men (Table 
4). In prior studies, moderate alcohol consumers (30-70 g alcohol per week)  had a lower risk 
of diabetic nephropathy (OR=0.36, 95% CI: 0.18-0.71) and diabetic retinopathy (OR=0.60, 
95% CI: 0.37-0.99) in patients with type 1 diabetes (Beulens et al. 2008). Alcohol has 
favourable effects on HDL-cholesterol, inflammation and inhibition of platelet aggregation 
 
Diet, Lifestyle and Chronic Complications in Type 1 Diabetic Patients 
 
39 
(Beulens et al. 2008). Because of this favourable effects we expect a beneficial effect on CVD, 
however to date no association was found between alcohol and CVD in type 1 diabetes 
patients (Bishop et al. 2009). In this cross-sectional study, markers for CVD were used 
instead of CVD as endpoint. Also the association between alcohol and diabetic nephropathy 
and diabetic retinopathy was only observed in cross-sectional studies. So the current 
recommendations for alcohol are confirmed by research in type 1 diabetes, but only based 
on cross-sectional studies, and especially for the association between alcohol and CVD in 
type 1 diabetic patients more research is needed. 
5.4 Physical activity 
There are no specific guidelines concerning physical activity for type 1 diabetic patients. The 
guidelines mentioned in Table 4 are only for type 2 diabetic patients. However, it was 
shown that the guidelines for type 2 diabetic patients are also applicable for type 1 diabetic 
patients. Several randomized controlled trials (Table 3) showed that physical activity 
(endurance sports; on average 2 times a week 60 minutes) improves physical fitness as well 
as endothelial function in type 1 diabetic patients (Lehmann R et al. 1997; Fuchsjäger-Mayrl 
G et al. 2002; Seeger JPH et al. 2011). Especially the improvement in endothelial function is 
important since endothelial dysfunction is an early sign of atherosclerosis, which is often the 
underlying cause of CVD. Also a positive effect on lipid related cardiovascular risk factors 
was found in one study (Lehmann R et al. 1997). However, also this conclusion should be 
interpreted carefully. Although the evidence is gained from randomized controlled trials, 
the conditions of these trials are really disappointing. They had a maximum sample size of 
23 people, and a minimum sample size of only 9 people. The follow-up period was 
relatively short, up to four months. The studies of Lehman et al. (Lehmann R et al. 1997) and 
Seeger et al. (Seeger JPH et al. 2011) not even used a control group. Furthermore CVD risk 
factors were used instead of CVD as endpoint. So the studies are in agreement with the 
guidelines but more research in better performed randomized controlled trials is needed to 
confirm this positive effect of physical activity on CVD in type 1 diabetic patients.  
6. Conclusion 
A diet high in fiber, low in saturated fat, moderate in protein intake with moderate alcohol 
consumption as well as physical activity can be recommended for type 1 diabetic patients to 
prevent complications. Inspite of the lack of large robust prospective studies, using the 
available evidence, we can conclude that diet as well as lifestyle could play an important 
role in preventing longterm complications of type 1 diabetes.  
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